MedTrace Logo

Characterizing HIV-related Diastolic Dysfunction

NCT02860156 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 195

Last updated 2019-03-04

No results posted yet for this study

Summary

This is a multicenter clinical trial of a cross section of HIV+ patients with and without diastolic dysfunction. Approximately 200 HAART-treated virally suppressed HIV+ subjects (100 HIV+/DD+ \& 100 HIV+/DD-) will be enrolled. This study will evaluate biomarkers, phenomapping, metabolomics, cMRI, echocardiography to determine characteristics unique to this patient population.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Kevin Anstrom, PhD · Duke University Health Services

  • Eugene Braunwald, MD · Harvard University

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-15
Primary Completion
2018-02-09
Completion
2018-02-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02860156 on ClinicalTrials.gov